Navigation Links
Pressure Cycling Technology (PCT) Highlighted in Five Podium Presentations at the Fifth International Conference on High Pressure; PBI Introduces the Patent-pending 'PCT Shredder' at the Meeting
Date:9/23/2008

actions. PBI currently holds 13 US and 6 foreign patents covering multiple applications of PCT in the life sciences field, including such areas as genomic and proteomic sample preparation, pathogen inactivation, the control of chemical reactions, immunodiagnostics, and protein purification.

Forward Looking Statements

Statements contained in this press release regarding the Company's intentions, hopes, beliefs, expectations, or predictions of the future are "forward-looking'' statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward looking statements include statements regarding the expected advantages of the Company's PCT Shredder, alone or in combination with the Company's Pressure Cycling Technology Sample Preparation System (PCT SPS), over other currently available sample preparation methods for processing ticks, muscle, seeds, and other very tough samples; the PCT Shredder method is more cost effective, less time-consuming, and less problematic than competitive methods; the breadth of applications afforded by PCT; that exposure at meetings such as HPBB will help PBI reach its goal of worldwide market leadership in high pressure bioscience and biotechnology; the advantages of PCT SPS over competitive processes; and the Company's goal of gaining greater market acceptance and penetration, and leadership in the worldwide sample preparation field. These statements are based upon the Company's current expectations, forecasts, and assumptions that are subject to risks, uncertainties, and other factors that could cause actual outcomes and results to differ materially from those indicated by these forward-looking statements. These risks, uncertainties, and other factors include, but are not limited to: unforeseen technological difficulties that the Company may encounter in the development of the PCT technology and products using the PCT technology; due to such unforeseen technical difficulties, or marketing, sales,
'/>"/>

SOURCE Pressure BioSciences, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Pressure BioSciences, Inc. Announces Research Agreement With the US Army Medical Research Institute of Infectious Diseases (USAMRIID)
2. Pressure BioSciences, Inc. Releases Novel, PCT-dependent Sample Preparation Kit for Systems Biology Studies
3. Pressure BioSciences, Inc. Reports Second Quarter 2008 Financial Results and Provides Business Update
4. Pressure BioSciences, Inc. to Discuss Second Quarter 2008 Financial Results and Provide Business Update
5. Pressure BioSciences, Inc. Announces the Market Release of its PCT-Enhanced Trypsin Digestion Application for Proteomics
6. Healthcare Industry Faces Mounting Pressure to Prevent On-The-Job Violence, Says Veteran Safety and Health Attorney
7. RADI Medical Systems Launches Next Generation PressureWire(R) Certus
8. Four Independent Research Groups Present Data Generated by Pressure Cycling Technology (PCT) at the ASMS Conference on Mass Spectrometry and Allied Topics in Denver, CO
9. InterCure Supports AHA Endorsement of Home Blood Pressure Monitoring
10. International Wound Care Experts, Medline Announce Pressure Ulcer Prevention Consensus Paper
11. Pressure BioSciences, Inc. to Discuss First Quarter 2008 Financial Results and Provide Business Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)LELYSTAD, The Netherlands, December 2 Pepscan Holding NV,the Netherlands based biotechnology company focusing on protein mimicking,technology for the generation of immune therapeutics today announced
(Date:12/2/2009)SINGAPORE, Dec. 2 S*BIO Pte Ltd today announced data presentations on its novel oral JAK2 inhibitor, SB1518, at The American Society of Hematology 51st Annual Meeting and Exposition in New Orleans. ,
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
(Date:12/2/2009)HOBOKEN, N.J., Dec. 2 According to the National Institute of Health, 40 percent to 45 percent of Americans diagnosed with diabetes already have some stage of diabetic retinopathy. Diabetic retinopat
Breaking Biology Technology:Dutch Biotech Company Pepscan Appoints New CEO 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...barely cover a human thumbnail, but they can hold ...cause this emerging technology offers a view of so...ct for studying relationships among the 30,000 gen... next major mysteries. , ,Biochips, essentially sl...m, give scientists a chance to look at bits of DNA...
... Computer Systems unit of Milwaukee-based Fiserv ...offer a product that verifies customers, identitie...nsightID provides access to billions of public rec...der of banking technology, and InsightAmerica, a s...nce to help prevent fraud losses from identity the...
...Sensient Technologies Corp. (NYSE:SXT) reported $...ues for its first quarter ended March 31. Diluted ...obal manufacturer and marketer of colors, flavors ...ce the same quarter last year. Total debt was $596... for the first quarter include a one-time expense ...
Other Biology Technology:Madison biochip research offers geneticists a big view through a small window 2Madison biochip research offers geneticists a big view through a small window 3
(Date:12/2/2009)...acculturated Latino men have a more difficult time...ated to U.S. culture, but acculturation has no aff...f these findings are published in Cancer Epidemio...merican Association for Cancer Research. The Decem...lturation affects smoking cessation differently fo...
(Date:12/2/2009)...e who smoke their first cigarette within minutes a..., a by-product of nicotine when processed by the b...he number of cigarettes smoked. , "Since cotin...er, our results suggest that smokers who smoke imm...r lung cancer," said researcher Joshua E. Muscat, ...
(Date:12/2/2009)...nce of a cancer-free status did not prompt people ...hy (CT) lung-cancer screening program to pick up t...y published in Cancer Epidemiology, Biomarkers & ... for Cancer Research. The December issue contains ...ld negate widespread concern in the lung screening...
Breaking Biology News(10 mins):Acculturation affects smoking cessation success among Latinos 2Increased nicotine levels detected in those who light-up earlier 2Repeat negative CT scan for lung cancer does not encourage ex-smokers to resume the habit 2Advanced Heart Procedure Treats Growing Problem 51120 1Advanced Heart Procedure Treats Growing Problem 51120 2Advanced Heart Procedure Treats Growing Problem 51120 3Screen All Newborns for Hip Dysplasia Study Urges 51115 1Screen All Newborns for Hip Dysplasia Study Urges 51115 2B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 1B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 2B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 3B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 4B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 5B Line Medical 28R 29 and Surgical Science Sign Data Integration Agreement for LapSim 28R 29 Simulator 51109 6
...rding to scientific gospel, social behavior is dic...as food, territory and reproduction. , That may we...breaking study researchers from the University of ...interactions among young mice result from basic mo... researchers say, the extent of a young mouse,s gr...
... fruit fly is able to locate and blissfully drown ...ially since its flight path seems to be so erratic...dy Reynolds at Rothamsted Research in the United K...Fruit flies explore their environment using a seri...° body-saccades. Some of these manoeuvres avoid ob...
...ts to developing new antibiotics, and a technique ...locking those secrets. , That,s the view of Unive...y, who will discuss his group,s progress toward th...ysical Society in Baltimore, Md. , Ramamoorthy,...re the germ-killing properties of natural antibiot...
Other Biology News:In young mice, gregariousness seems to reside in the genes 2In young mice, gregariousness seems to reside in the genes 3Flies don't buzz about aimlessly! 2Natural antibiotics yield secrets to atom-level imaging technique 2Natural antibiotics yield secrets to atom-level imaging technique 3
IMAGEQUANT 400 WKSTN from GE Healthcare, formerly Amersham Biosciences
Rabbit Anti-Human IFN-Alpha / Beta R2 (IFNAR2) (CD118) Neutralizing Polyclonal Antibody, Unconjugated from PBL InterferonSource
Rabbit Anti-MYCOBACTERIUM TUBERCULOSIS Polyclonal Antibody, Unconjugated from AbD Serotec
ImageQuant 400 from GE Healthcare, formerly Amersham Biosciences
Biology Products: